首页 > 市场调查报告书 > 製药

非专利药糖尿病生物製剂生技仿製药

市场调查报告书

商品编码

1741312

胰岛素拮抗剂市场按胰岛素拮抗剂类型、适应症、给药途径、通路和地区划分

Insulin Sensitizers Market, By Type of Insulin Sensitizers, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

胰岛素拮抗剂市场规模预计在 2025 年为 237.7 亿美元，预计到 2032 年将达到 367 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.4%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	237.7亿美元
效能数据	2020-2024	预测期	2025-2032
预测期间：2025年至2032年的复合年增长率	6.40%	2032年价值预测	367亿美元

胰岛素拮抗剂是改善胰岛素敏感性并降低血糖值的药物。它们也被称为降血糖药或降血糖药，有助于在不使用胰岛素的情况下将血糖值恢復到正常范围。它们透过提高肝臟、肌肉和脂肪细胞对胰岛素的敏感性来发挥作用。胰岛素拮抗剂有多种类型，包括Metformin(Met)、PIOGLITAZONE(Pio)、噻唑烷二酮 (TZD) 和肌醇。

市场动态

全球胰岛素拮抗剂市场的成长是由糖尿病，特别是第 2 型糖尿病的盛行率不断上升所驱动。胰岛素拮抗剂经常用于治疗第 2 型糖尿病，以增强胰岛素敏感性和控制血糖值。肥胖会显着增加第 2 型糖尿病和胰岛素抗性。由于全球肥胖盛行率不断上升，有效的胰岛素拮抗剂可以帮助控制胰岛素阻抗和相关代谢疾病。正在进行的研究和开发活动正在产生创新的化合物和製剂，推出新的和增强的胰岛素拮抗剂，以提高治疗胰岛素敏感性药物的有效性和安全性。此外，各国政府正采取多项倡议来对抗糖尿病。计划和方案的重点是传播有关糖尿病的知识、早期发现糖尿病以及推广必要且负担得起的治疗方法，如胰岛素拮抗剂。

与任何药物一样，胰岛素拮抗剂也存在潜在的副作用，包括体重增加、体液储存、骨折以及心臟衰竭风险增加。某些类型的胰岛素拮抗剂，例如噻唑烷二酮类药物 (TZD)，可能引发安全性问题，从而限制了其使用和广泛接受。

研究的主要特点

本报告对全球胰岛素拮抗剂市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球胰岛素拮抗剂市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球胰岛素拮抗剂市场报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过全球胰岛素拮抗剂市场分析中使用的各种策略矩阵更轻鬆地做出决策。

市场动态
- 驱动程式
糖尿病盛行率不断上升
全球肥胖症疫情日益严重
药物研发进展
政府的积极倡议
- 限制因素
副作用和安全问题
在某些患者族群中疗效有限
监管挑战和市场进入
- 机会
新兴经济体
个人化医疗
联合治疗
非糖尿病应用
影响分析
监管情景
产品发布/核准
PEST分析
波特分析
併购场景

4. 全球胰岛素拮抗剂市场-冠状病毒（COVID-19）大流行的影响

COVID-19流行病学
供需侧分析
经济影响

5. 2020 年至 2032 年全球胰岛素拮抗剂市场（按胰岛素拮抗剂类型）

介绍
胰岛素增敏剂（TZD）
双胍类
Incretin-based的治疗方法
其他的

6. 全球胰岛素拮抗剂市场（依适应症分类），2020 年至 2032 年

介绍
2型糖尿病
糖尿病前期
卵巢症候群（PCOS）

7. 2020-2032 年全球胰岛素拮抗剂市场（依给药途径）

介绍
口服
注射

8. 全球胰岛素拮抗剂市场（依分销管道划分），2020-2032 年

介绍
医院药房
零售药局
网路药局

9. 全球胰岛素拮抗剂市场（按地区划分），2020-2032 年

介绍
北美洲
欧洲
亚太地区
拉丁美洲
中东和非洲

第十章竞争格局

Eli Lilly and Company
Novo Nordisk
Sanofi
Merck & Co.
Bristol Myers Squibb
AstraZeneca
Boehringer Ingelheim
Johnson & Johnson
Takeda Pharmaceutical

第 11 章章节

调查方法
关于出版商

简介目录

Product Code: CMI6069

Insulin Sensitizers Market is estimated to be valued at USD 23.77 Bn in 2025 and is expected to reach USD 36.7 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 23.77 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.40%	2032 Value Projection:	USD 36.7 Bn

Insulin sensitizers are medications that improve insulin sensitivity and reduce blood sugar levels. These are also known as blood sugar normalizing agents and euglycemics, and these help in returning blood glucose to the normal range without using insulin. These work by increasing liver, muscle and fat cells' sensitivity to insulin. There are several different types of insulin sensitizers including metformin (Met), pioglitazone (Pio), thiazolidinediones (TZDs), and inositols.

Market Dynamics

Global insulin sensitizers market growth is driven by increased prevalence of diabetes, especially type 2 diabetes. Insulin sensitizers are frequently used to increase insulin sensitivity and manage blood glucose levels in the treatment of type 2 diabetes. Type 2 diabetes and insulin resistance are both significantly increased by obesity. Effective insulin sensitizer helps in controlling insulin resistance and related metabolic diseases due to rising prevalence of obesity worldwide. The ongoing research and development activities have introduced new and enhanced insulin sensitizers that creates innovative compounds and formulation methods, and improves the efficacy and safety profiles of drugs that treat insulin sensitivity. Furthermore, the governments have taken several initiatives to combat diabetes. The plans and the programs focus on spreading knowledge about diabetes, early detection of diabetes and facilitating necessary and affordable treatments like insulin sensitizers.

Like any drugs, insulin sensitizers have potential side effects like weight gain, fluid retention, bone fractures, and an elevated risk of heart failure. Specific kinds of insulin sensitizers such as thiazolidinediones (TZDs) may create worries about its safety concern, thus, restricting their use and make them difficult to embrace widely.

Key features of the study:

This report provides in-depth analysis of the global insulin sensitizers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global insulin sensitizers market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Eli Lilly and Company, Novo Nordisk, Sanofi, Merck & Co., Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Takeda Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global insulin sensitizers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insulin sensitizers market

Insulin Sensitizers Market Detailed Segmentation:

By Type:
- Thiazolidinediones (TZDs)
- Biguanides
- Incretin-based therapies
- Others
By Indication:
- Type 2 Diabetes
- Prediabetes
- Polycystic Ovary Syndrome (PCOS)
By Route of Administration:
- Oral
- Injectable
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Eli Lilly and Company
- Novo Nordisk
- Sanofi
- Merck & Co.
- Bristol Myers Squibb
- AstraZeneca
- Boehringer Ingelheim
- Johnson & Johnson
- Takeda Pharmaceutical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Insulin Sensitizers
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of diabetes
Growing global obesity epidemic
Advancements in drug development
Favorable government initiatives
- Restraints
Adverse effects and safety concerns
Limited efficacy in certain patient populations
Regulatory challenges and market access
- Opportunities
Emerging economies
Personalized medicine
Combination therapies
Non-diabetic applications
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Insulin Sensitizers Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Insulin Sensitizers Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Thiazolidinediones (TZDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Biguanides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Incretin-based therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Insulin Sensitizers Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn )
Prediabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Polycystic Ovary Syndrome (PCOS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Insulin Sensitizers Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Insulin Sensitizers Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Insulin Sensitizers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

10. Competitive Landscape

Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

胰岛素拮抗剂市场按胰岛素拮抗剂类型、适应症、给药途径、通路和地区划分